Who
Karen Marie Johnson
Director
Company insider
Files Form 4 as: Director, The Oncology Institute.
In numbers
- Trades disclosed
- 12
- Buys
- 1
- Sells
- 0
- Bought
- $38K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 21 Mar 2022
- Last trade
- 27 Jul 2026
- Last filed
- 29 Jul 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Jul 2026filed 29 Jul 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —31,124 at $0.00 | filing |
| 27 Jul 2026filed 29 Jul 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —31,124 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —47,840 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —37,037 at $0.00 | filing |
| 26 Mar 2025filed 28 Mar 2025 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code P | $2,35518,112 at $0.13 | filing |
| 26 Mar 2025filed 28 Mar 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $38K36,224 at $1.04 | filing |
| 22 Nov 2024filed 25 Nov 2024 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —52,000 at $0.00 | filing |
| 26 Dec 2023filed 28 Dec 2023 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —52,000 at $0.00 | filing |
| 17 Mar 2023filed 21 Mar 2023 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —19,685 at $0.00 | filing |
| 17 Nov 2022filed 21 Nov 2022 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —22,708 at $0.00 | filing |
| 21 Mar 2022filed 23 Mar 2022 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —15,994 at $0.00 | filing |
| 21 Mar 2022filed 23 Mar 2022 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —4,798 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.